Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 22, Issue 3, Pages 308-317Publisher
SAGE PUBLICATIONS INC
DOI: 10.1097/00004647-200203000-00008
Keywords
MCP-1; chemokines; cytokines; neuroinflammation; focal cerebral ischemia; astrocytes; microglia
Categories
Ask authors/readers for more resources
Inflammatory processes have been implicated in the pathogenesis of brain damage after stroke. In rodent stroke models, focal ischemia induces several proinflammatory chemokines. including monocyte chemoattractant protein-1 (MCP-1) The individual contribution to ischemic tissue damage, however, is largely unknown. To address this question, the authors subjected MCP-1-deficient mice (MCP-l(-/-)) to permanent middle cerebral artery occlusion (MCAO). Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between wild-type (wt) and MCP-1(-/-) mice. MCAO led to similar cerebral perfusion deficits in wt and MCP-1(-/-) mice, excluding differences in the MCA supply territory and collaterals. However, compared with wt mice, the mean infarct volume was 29% smaller in MCP-1(-/-) mice 24 hours after MCAO (P = 0.022). Immunostaining showed a reduction of phagocytic macrophage accumulation within infarets and the infarct border in MCP-1(-/-) mice 2 weeks after MCAO. At the same time point, the authors found an attenuation of astrocytic hypertrophy in the infarct border and thalamus in MCP-1(-/-) mice. However, these effects on macrophages and astrocytes in MCP-l(-/-) mice occurred too late to suggest a protective role in acute infarct growth. Of note: at 6 hours after MCAO, MCP-1(-/-) mice produced significantly less interleukin-1beta in ischemic tissue: this might be related to tissue protection. The results of this study indicate that inhibition of MCP-1 signaling could be a new acute treatment approach to limit infaret size after stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available